Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France

Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France

We analyzed demographic characteristics, comorbidities and patterns of treatment with tyrosine kinase inhibitors (TKIs) in a cohort of 3,633 incident cases of chronic myeloid leukemia (CML) identified across France from 1 January 2011 to 31 December 2014. Patients were identified through a specific...

Full description

Bibliographic Details
Main Authors: Marie Pajiep, Cécile Conte, Françoise Huguet, Martin Gauthier, Fabien Despas, Maryse Lapeyre-Mestre
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
chronic myeloid leukemia
incidence
polypharmacy
comorbidities
first line treatment
tyrosine kinase inhibitors (TKI)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.675609/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.675609/full

Similar Items